One-Third of FDA-Approved Drugs Subject to Later Safety Issues

Nearly one-third of all drugs approved for sale in the U.S. over a 10-year period were subject to post-approval “safety events” such as warnings in their labels and safety advisories to doctors and the public, Yale University researchers have found.

from WSJ.com: US Business http://ift.tt/2qYI3Vf
via IFTTT